{{author}}{{author}}{{($index < metadata.AuthorsAndEtalArray.length-1) ? ',' : '.'}}

Nicola Clibbens, John Baker, Andrew Booth, Kathryn Berzins, Michael C Ashman, Leila Sharda, Jill Thompson, Sarah Kendal & Scott Weich.

Nicola Clibbens ^1,2,3,4,*, John Baker ^1,5, Andrew Booth ⁶, Kathryn Berzins ¹, Michael C Ashman ^1,7, Leila Sharda ¹, Jill Thompson ⁸, Sarah Kendal ¹, Scott Weich ^2,6

¹ School of Healthcare, University of Leeds, Leeds, UK
² Sheffield Health and Social Care NHS Foundation Trust, Sheffield, UK
³ Department of Nursing, Midwifery and Health, Northumbria University, Newcastle upon Tyne, UK
⁴ Cumbria, Northumberland, Tyne and Wear NHS Foundation Trust, Newcastle upon Tyne, UK
⁵ Leeds and York Partnership NHS Foundation Trust, Leeds, UK
⁶ School of Health and Related Research, University of Sheffield, Sheffield, UK
⁷ Independent consultant, ,
⁸ Health Sciences School, University of Sheffield, Sheffield, UK
^* Corresponding author Email: Nicola.clibbens@northumbria.ac.uk

Disclosure of interests

Full disclosure of interests: Completed ICMJE forms for all authors, including all related interests, are available in the toolkit on the NIHR Journals Library report publication page at https://doi.org/10.3310/TWKK5110.

Primary conflicts of interest: Nicola Clibbens is a member of the National Institute for Health and Care Research (NIHR) Research for Patient Benefit funding panel for Yorkshire and the North East of England (2021–24). She also declares that pre-protocol funding was provided by Sheffield Health and Social Care NHS Foundation Trust (2018). John Baker is committee chairperson for the Health Education England/NIHR Integrated Clinical and Practitioner Academic Programme (February 2022 to present); he was a member of the NIHR Advanced Fellowship funding panel (September 2015 to February 2022) and was a non-executive director of the Leeds and York Partnership NHS Foundation Trust (August 2016 to August 2022). Andrew Booth declares previous membership of the NIHR Evidence Synthesis Programme Advisory Group and Programme Grants Committee (September 2018 to August 2022), the Systematic Reviews NIHR Cochrane Incentive Awards (2019–20), the NIHR Evidence Synthesis Incentive Awards Committee (2021–22) and the NIHR HSDR Funding Committee (September 2018 to November 2022), and declares current membership of the NIHR Complex Review Support Unit Funding Board (2017 to present) and the HSDR Unmet Needs Sub-Committee (November 2019 to present). Scott Weich was a member, and later chairperson, of the NIHR Health Technology Assessment (HTA) Psychological and Community Therapies Panel and its predecessors and the NIHR HTA Prioritisation Strategy Group (2007–16), and the HTA Funding Committee Clinical Evaluation and Trials (1 November 2015 to 30 November 2019), and was a member of the HTA Programme Oversight Committee (2012–16).